Sfoglia per AUTORE
RAY-COQUARD I
Collezione AO Ordine Mauriziano

  

Items : 8

Is total mesorectal excision mandatory in advanced ovarian cancer patients undergoing posterior pelvic exenteration? Prognostic role of mesorectal space involvement in a prospective ovarian cancer cohort. in European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology / Eur J Surg Oncol. 2025 Mar 6;51(7):109749. doi: 10.1016/j.ejso.2025.109749.

2025
AO Ordine Mauriziano
AOU Città della Salute di Torino

Ray-Coquard I; Meeus P; Le Saux O; Borella F; Rossi L; Russo C; Chiadó F; Fuso L; Ferraioli D; Chopin N;

Should all advanced BRCA-mutated patients in response to first-line platinum-based chemotherapy receive PARPi + bevacizumab as maintenance therapy? in ESMO open / ESMO Open. 2024 May;9(5):102983. doi: 10.1016/j.esmoop.2024.102983. Epub 2024 Apr 24.

2024
AO Ordine Mauriziano

Turinetto M; Ray-Coquard I; Gourley C;

Correction: Clinical and Histopathological Predictors of Recurrence in Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers. in Annals of surgical oncology / Ann Surg Oncol. 2022 Dec;29(13):8319. doi: 10.1245/s10434-022-12594-x.

2022
AO Ordine Mauriziano

Borella F; Cosma S; Ferraioli D; Ray-Coquard I; Chopin N; Meeus P; Cockenpot V; Valabrega G; Scotto G; Turinetto M; Biglia N; Fuso L; Mariani L; Franchi D; Vidal Urbinati AM; Pino I; Bertschy G; Preti M; Benedetto C; Castellano I; Cassoni P; Bertero L;

Clinical and Histopathological Predictors of Recurrence in Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers. in Annals of surgical oncology / Ann Surg Oncol. 2022 Dec;29(13):8302-8314. doi: 10.1245/s10434-022-12353-y. Epub 2022 Aug 17.

2022
AO Ordine Mauriziano

Borella F; Cosma S; Ferraioli D; Ray-Coquard I; Chopin N; Meeus P; Cockenpot V; Valabrega G; Scotto G; Turinetto M; Biglia N; Fuso L; Mariani L; Franchi D; Vidal Urbinati AM; Pino I; Bertschy G; Preti M; Benedetto C; Castellano I; Cassoni P; Bertero L;

Impact of multidisciplinary tumour board in the management of ovarian carcinoma in the first-line setting. Exhaustive analysis from the Rhone-Alpes region. in European journal of cancer care / Eur J Cancer Care (Engl). 2020 Nov;29(6):e13313. doi: 10.1111/ecc.13313. Epub 2020 Sep 7.

2020
AO Ordine Mauriziano

Ferraioli D; Bally O; Meeus P; Benayoun D; Bakrin N; De Saint Hilaire P; Beal Ardisson D; Provençal J; Barletta H; Mousseau M; Chauleur C; Verbaere S; Knibiehly A; Fuso L; Charreton A; Devouassoux-Shisheboran M; Chopin N; Glehen O; Labrosse-Canat H; Farsi F; Ray-Coquard I;

Erratum to: Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy. in Targeted oncology / Target Oncol. 2016 Jun;11(3):429. doi: 10.1007/s11523-016-0433-x.

2016
AO Ordine Mauriziano

Despierre E; Vergote I; Anderson R; Coens C; Katsaros D; Hirsch FR; Boeckx B; Varella-Garcia M; Ferrero A; Ray-Coquard I; Green JA; Steer C; Berns EM; Casado A; Lambrechts D; Jimeno A;

Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy. in Targeted oncology / Target Oncol. 2015 Dec;10(4):583-96. doi: 10.1007/s11523-015-0369-6.

2015
AO Ordine Mauriziano

Despierre E; Vergote I; Anderson R; Coens C; Katsaros D; Hirsch FR; Boeckx B; Varella-Garcia M; Ferrero A; Ray-Coquard I; Berns EM; Casado A; Lambrechts D; Jimeno A;

Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: a European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group, and Gynecologic Cancer Intergroup study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2014 Feb 1;32(4):320-6. doi: 10.1200/JCO.2013.50.5669. Epub 2013 Dec 23.

2014
AO Ordine Mauriziano

Vergote IB; Jimeno A; Joly F; Katsaros D; Coens C; Despierre E; Marth C; Hall M; Steer CB; Colombo N; Lesoin A; Casado A; Reinthaller A; Green J; Buck M; Ray-Coquard I; Ferrero A; Favier L; Reed NS; Curé H; Pujade-Lauraine E;